drugset / Trial / NCT01732692
Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel Preparation
RandomizedParallel-groupSingle-blindTreatment
Summary
To compare colon cleansing quality induced by the 2 different modes of MOVIPREP® intake in 5 colon segments prior to colonoscopy.
Timeline
- Start
- 2012-11
- Primary completion
- 2013-04
- Completion
- 2013-04
Outcome
Met primary endpoint
registry analysis (non-inferiority or equivalence test); MOVIPREP (Morning-only Dose) vs MOVIPREP (Split-dose); p <0.001; Treatment Difference 0.0286; Exact Farrington - Manning NCT01732692 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Moviprep | Other / unclassified | 2000 ml | — |
Indications
No indication recorded.